Harnessing Artificial Intelligence for Global Health Advancement. Journal of Data Analysis and Information Processing, 13, 66 ...

Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” or the “Company”), a clinical-stage biotechnology company pioneering innovative cancer and viral infection treatments, today announced the ...

Such growth makes China an increasingly important player in the global biopharmaceutical industry, offering potential market ...

IceCure Medical (ICCM) has submitted a regulatory filing with China’s National Medical Products Administration for the approval of its ProSense Cryoablation System. IceCure’s IceSense3 ...

LIFE SAVING MEDICAL DEVICE SYSTEMS. THIS IS A CRITICAL CARE LINE. THIS IS WHERE WE MAKE OUR BLOOD GAS ANALYZERS. MARK OLSON IS THE CHIEF MANUFACTURING OFFICER FOR WARFARIN. THIS MASSACHUSETTS ...

today announced it has submitted a regulatory filing with China's National Medical Products Administration ("NMPA") for the approval of its ProSense® Cryoablation System. IceCure's IceSense3 ...

The National Testing House (NTH) currently lacks the expertise and capacity to comprehensively test and certify radiation-emitting medical devices, despite existing regulatory oversight from the ...

MINNEAPOLIS, Jan. 23, 2025 /PRNewswire/ -- Saluda Medical, Inc., a pioneer in the development and commercialization of a novel neuromodulation platform designed to transform the lives of patients ...

The FSC, which regulates securities, insurance, pensions, and corporate services, is responsible for granting this approval ... Andrae Tulloch, chief regulatory officer of the JSE, noted that ...

The post-market surveillance (PMS) regulation for medical devices comes into force across England, Scotland and Wales on 16 June 2025 and introduces key new requirements around the monitoring of ...

The Trilogy valve. [Image from the JenaValve website] GlobalData analysts anticipate FDA approval for the JenaValve Trilogy TAVR device designed to treat aortic regurgitation (AR) this year.